Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP592583.RAIdc0pDgUq0r8BFmYwgK_FFhnludLSJRcWm-zTr6Qb_w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP592583.RAIdc0pDgUq0r8BFmYwgK_FFhnludLSJRcWm-zTr6Qb_w130_assertion type Assertion NP592583.RAIdc0pDgUq0r8BFmYwgK_FFhnludLSJRcWm-zTr6Qb_w130_head.
- NP592583.RAIdc0pDgUq0r8BFmYwgK_FFhnludLSJRcWm-zTr6Qb_w130_assertion description "[It is fairly well accepted that the presence of estrogen receptor (ER) and progesterone receptor (PgR) identifies breast cancer patients with a lower risk of relapse and better overall survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP592583.RAIdc0pDgUq0r8BFmYwgK_FFhnludLSJRcWm-zTr6Qb_w130_provenance.
- NP592583.RAIdc0pDgUq0r8BFmYwgK_FFhnludLSJRcWm-zTr6Qb_w130_assertion evidence source_evidence_literature NP592583.RAIdc0pDgUq0r8BFmYwgK_FFhnludLSJRcWm-zTr6Qb_w130_provenance.
- NP592583.RAIdc0pDgUq0r8BFmYwgK_FFhnludLSJRcWm-zTr6Qb_w130_assertion SIO_000772 1728420 NP592583.RAIdc0pDgUq0r8BFmYwgK_FFhnludLSJRcWm-zTr6Qb_w130_provenance.
- NP592583.RAIdc0pDgUq0r8BFmYwgK_FFhnludLSJRcWm-zTr6Qb_w130_assertion wasDerivedFrom befree-2016 NP592583.RAIdc0pDgUq0r8BFmYwgK_FFhnludLSJRcWm-zTr6Qb_w130_provenance.
- NP592583.RAIdc0pDgUq0r8BFmYwgK_FFhnludLSJRcWm-zTr6Qb_w130_assertion wasGeneratedBy ECO_0000203 NP592583.RAIdc0pDgUq0r8BFmYwgK_FFhnludLSJRcWm-zTr6Qb_w130_provenance.